Insider Transactions in Q4 2024 at An2 Therapeutics, Inc. (ANTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2024
|
Kabeer Aziz |
BUY
Grant, award, or other acquisition
|
Direct |
8,972
+50.0%
|
-
|
|
Dec 19
2024
|
Patricia A. Martin |
BUY
Grant, award, or other acquisition
|
Direct |
3,166
+50.0%
|
-
|
|
Dec 19
2024
|
Gilbert Lynn Marks |
BUY
Grant, award, or other acquisition
|
Direct |
8,972
+22.0%
|
-
|
|
Dec 19
2024
|
Robin Shane Readnour |
BUY
Grant, award, or other acquisition
|
Direct |
9,077
+50.0%
|
-
|
|
Dec 19
2024
|
Joseph S Zakrzewski |
BUY
Grant, award, or other acquisition
|
Direct |
9,816
+6.78%
|
-
|
|
Dec 10
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.81%
|
$10,000
$1.49 P/Share
|
|
Dec 09
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
30,772
+2.43%
|
$30,772
$1.43 P/Share
|
|
Dec 06
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
19,228
+1.61%
|
$19,228
$1.45 P/Share
|
|
Nov 27
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
50,000
+4.1%
|
$50,000
$1.42 P/Share
|
|
Nov 27
2024
|
Joseph S Zakrzewski |
BUY
Open market or private purchase
|
Direct |
2,000
+1.57%
|
$2,000
$1.4 P/Share
|
|
Nov 26
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
25,000
+2.18%
|
$25,000
$1.39 P/Share
|
|
Nov 20
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
50,000
+4.36%
|
$50,000
$1.16 P/Share
|
|
Nov 19
2024
|
Robin Shane Readnour |
BUY
Open market or private purchase
|
Indirect |
150,000
+12.54%
|
$150,000
$1.04 P/Share
|
|
Nov 19
2024
|
Joseph S Zakrzewski |
BUY
Open market or private purchase
|
Direct |
5,000
+3.9%
|
$5,000
$1.01 P/Share
|
|
Nov 18
2024
|
Joseph S Zakrzewski |
BUY
Open market or private purchase
|
Direct |
20,000
+14.47%
|
$20,000
$1.0 P/Share
|
|
Nov 18
2024
|
Eric Easom Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
50,000
+4.48%
|
$50,000
$1.0 P/Share
|
|
Nov 04
2024
|
Stephen David Prior Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,125
+22.27%
|
-
|
|
Nov 04
2024
|
Joshua M Eizen |
BUY
Grant, award, or other acquisition
|
Direct |
31,500
+19.96%
|
-
|